CEO and Co-founder
T3 Pharmaceuticals
T3 Pharmaceuticals develops targeted therapies utilizing proprietary drug delivery systems to enhance the efficacy of treatments for cancer patients. The company focuses on improving patient outcomes by increasing the precision of drug administration while minimizing side effects associated with traditional cancer therapies.
- Biotechnology
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- T3 Pharmaceuticals develops targeted therapies utilizing proprietary drug delivery systems to enhance the efficacy of treatments for cancer patients. The company focuses on improving patient outcomes by increasing the precision of drug administration while minimizing side effects associated with traditional cancer therapies.